A test for COVID-19 uses a ‘reverse transcription polymerase chain reaction’ (RT-PCR). The RNA in the sample is extracted and converted to DNA, which is then amplified using “primers”– short synthesised fragments of nucleic acid. A fluorescent dye (called a “probe”) is introduced, and the sample illuminates only in the presence of DNA.
We spoke to V Ravi, senior professor and head, public health virology, with the National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, to understand how this test works.
As of 21 March 2020, India has 258 confirmed cases of COVID19, a novel coronavirus that has affected more than 275,000 people and killed more than 11,000 globally. About 9 percent (23 of 258) patients in India have been discharged, while four people have died, according to Coronavirus Monitor, a HealthCheck database.

